case_images: PMC11729262_01
case_images: Liver histology of the patient. (A) Hematoxylin-eosin staining. (B) Reticular fibrous staining.
case_images: medi-104-e41103-g001.jpg
case_images: PMC11729262_02_medi-104-e41103-g001.jpg
case_images: F1
case_images: The specific treatment regimen and monitoring of various indicators are depicted in Figures 2 and 3, and Table 1.
case_images: PMC11729262_02
case_images: Liver histology of the patient. (A) Hematoxylin-eosin staining. (B) Reticular fibrous staining.
case_images: medi-104-e41103-g001.jpg
case_images: PMC11729262_02_medi-104-e41103-g001.jpg
case_images: F1
case_images: The specific treatment regimen and monitoring of various indicators are depicted in Figures 2 and 3, and Table 1.
case_images: Treatment process. W = weeks; qd = quaque die; qod = quaque omni die; qw = quaque week; LAM = lamivudine; ETV = entecavir; IFNalpha = interferon alpha; PEG IFNalpha = pegylated interferon alpha.
case_images: medi-104-e41103-g002.jpg
case_images: PMC11729262_02_medi-104-e41103-g002.jpg
case_images: F2
case_images: The specific treatment regimen and monitoring of various indicators are depicted in Figures 2 and 3, and Table 1.
case_images: Changes of HBsAg and HBsAb during treatment and follow-up. HBsAg = hepatitis B surface antigen; HBsAb = hepatitis B surface antibody.
case_images: medi-104-e41103-g003.jpg
case_images: PMC11729262_02_medi-104-e41103-g003.jpg
case_images: F3
case_images: The specific treatment regimen and monitoring of various indicators are depicted in Figures 2 and 3, and Table 1.